HOME >> MEDICINE >> NEWS
UK and other European countries should introduce universal childhood hepatitis B vaccination

most effective means of reducing the global burden of a particular disease. It also protects children before they are at risk of infection, and vaccines available today can immunise individuals for life with no need for additional booster vaccinations. Disadvantages include cost-effectiveness in countries of low endemicity and concerns about adding another vaccine into the childhood vaccination programme.

The advantages of the at-risk strategy are that an immediate impact within the target group can be obtained, with low cost in countries with low endemicity. Disadvantages include leaving the general population at risk, the difficulties in properly identifying at risk groups and the social stigma of being defined at-risk.

The authors conclude that on the basis of current experience and evidence, the UK, Ireland, Finland, Iceland, the Netherlands, Norway, Sweden, and Denmark should all adopt a universal vaccination policy.

They say: Global hepatitis B universal vaccination is ultimately the only way to eliminate HBV transmission and new cases of hepatitis B. Indeed, global efforts to control and prevent hepatitis B are of crucial importance and it is the responsibility of each country worldwide to play its part.


'"/>

Contact: Dr. Jane Zuckerman
j.zuckerman@medsch.ucl.ac.uk
44-779-887-6445
Lancet
5-Jun-2007


Page: 1 2

Related medicine news :

1. Chemotherapy with bevacizumab increases risk of blood clots in arteries
2. Nonsmall cell lung cancer -- chemotherapy before surgery appears better than surgery alone
3. Borderline personality disorder shows improvements with intensive psychotherapy
4. Trial shows circulating tumor cells predict how prostate cancer patients do with chemotherapy
5. Chemotherapy may enhance the effectiveness of brain tumor vaccines
6. Brain-boosting pill alleviates post-chemotherapy fogginess
7. Adding radioimmunotherapy to chemo may help patients with lymphoma
8. Pre-operative chemotherapy does not increase survival rates for nonsmall cell lung cancer
9. Medical management of another condition may not lead to early cancer diagnosis
10. OHSU Cancer Institute shows findings of immunotherapy vaccine in prostate cancer patients
11. New mothers often not asked about depression, UNC survey finds

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/23/2017)... ... ... Mill”: a story of love and redemption, hope and uncertainty as a girl makes ... “The Inn at the Mill” is the creation of published author, Lois Kulp, who was ... in Berks County on Crow Hill. The inn, the mill and "Post Yokel" ...
(Date:1/23/2017)... ... ... “Some Infallible Characteristics of Christ”: a fascinating and entrancing novel exploring the ... of published author, Rev. Dr. Robert W. Thomas, the third of seven siblings. He ... nineteen, a pastor for over fifteen years. He is a graduate of N.C. College ...
(Date:1/22/2017)... ... January 22, 2017 , ... "Photo Cloud allows FCPX users to add ... slideshow with complete ease," said Christina Austin - CEO of Pixel Film Studios. ... FCPX timeline. Presets include scenes with one, three, four or five focus ...
(Date:1/21/2017)... ... ... is the perfect set of tools for video editors that want to create the illusion ... - CEO of Pixel Film Studios. , Video editors using ProDOF can add realistic ... racking focus from one area into the next. ProDOF comes with 0.5 second, 1.0 ...
(Date:1/21/2017)... ... January 21, 2017 , ... Northern California ... has recently joined their multi-specialty medical group. The dermatology practice provides general dermatologic ... “We’re excited to add this excellent dermatology practice to our group’s medical services,” ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... Stock-Callers.com today presents the following Generic ... CPRX ), Sophiris Bio Inc. (NASDAQ: SPHS ), ... Therapeutics Inc. (NASDAQ: AGRX ). These companies are ... late trade on Friday, January 20 th , 2017, with ... of health care companies in the S&P 500 also were ...
(Date:1/23/2017)... -- ResMed (NYSE : RMD), BMC (Pékin, Chine) et 3B Medical ... se sont mis d,accord sur le règlement mondial de ... 3B seront autorisés à vendre leurs produits existants en ... effectuera le paiement de la décision en une seule ... entre les deux parties. Le règlement n,inclut pas l,admission ...
(Date:1/23/2017)... Jan 23, 2017 InDex Pharmaceuticals Holding AB ... the 12th congress of the European Crohn,s and Colitis Organisation (ECCO). ... a specific focus on inflammatory bowel disease (IBD). The congress is ... 2017. ... are pleased to again having been selected to present data at ...
Breaking Medicine Technology:
Cached News: